NDC11 00409140105
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00409-1401-05 | 00409-1401 |
| 00409-1401-5 | 00409-1401 |
| 0409-1401-05 | 0409-1401 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Regadenoson | REGADENOSON | Hospira, Inc. | 0e3f080d-b1fb-47ed-8cd3-90a4206fa704 | 2025-12-08 | Warnings, Adverse reactions | 0409-1401-05 0409-1401 00409140105 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.